{"DataElement":{"publicId":"6001384","version":"1","preferredName":"Non-Target Lesion Response irRECIST Type","preferredDefinition":"Text term to represent disease response in a non-target lesion using the irRECIST criteria.","longName":"NTGT_LES_RESP_IRR_TP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2188868","version":"1","preferredName":"Non-Target Lesion Response","preferredDefinition":"Information relating to non-target lesion response.","longName":"NTRGET_LES_RESP","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206599","version":"1","preferredName":"Non-Target Lesion","preferredDefinition":"Other than the one for which something is done.:(LEE-zhun) An area of abnormal tissue change.","longName":"C25592:C3824","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Target","conceptCode":"C25592","definition":"Other than the one for which something is done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FBB9-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177336","version":"1","preferredName":"Response","preferredDefinition":"Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"Response","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528C-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Denise Warzel updated Definition by seraching NCI Thesaurus in Admin tool.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E49C180D-8D36-0916-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-10-05","modifiedBy":"SOKKERL","dateModified":"2017-10-19","changeDescription":"8/30/17 tt transferred context, added registration status and CSI per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6001382","version":"1","preferredName":"irRECIST Non-Target Type","preferredDefinition":"A set of criteria for capturing the unidimensional measurements which are used to assess the effect of immunotherapeutic agents on solid tumors. These criteria are based on elements of the Immune-Related Response Criteria (irRC) and Immune-related RECIST (irRECIST)._Other than the one for which something is done._Something distinguishable as an identifiable class based on common qualities.","longName":"6001382v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"3","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"irCR","valueDescription":"irCR","ValueMeaning":{"publicId":"6001372","version":"1","preferredName":"irCR","longName":"6001372","preferredDefinition":"A complete disappearance of  all measurable and non-measurable lesions. Lymph nodes must decrease to less than 10 mm in short axis. Confirmation of response is not mandatory.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"irRECIST Complete Response","conceptCode":"C140316","definition":"A complete disappearance of all measurable and non-measurable lesions. Lymph nodes must decrease to < 10 mm in short axis. Confirmation of response is not mandatory.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B46FAD0-75C8-3F97-E053-F662850A260F","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"KUMMEROA","dateModified":"2022-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B4757C3-0019-07ED-E053-F662850A267F","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"ONEDATA","dateModified":"2017-10-11","deletedIndicator":"No"},{"value":"irPD","valueDescription":"irPD","ValueMeaning":{"publicId":"6001374","version":"1","preferredName":"irPD","longName":"6001374","preferredDefinition":"A minimum 20% increase and minimum 5 mm absolute increase in total measured tumor burden compared to nadir, or irPD for non-target or new non-measurable lesions. Confirmation of progression is recommended minimum 4 weeks after the first irPD assessment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"irRECIST Progressive Disease","conceptCode":"C140319","definition":"A minimum 20% increase and minimum 5 mm absolute increase in total measured tumor burden compared to nadir, or irPD for non-target or new non-measurable lesions. Confirmation of progression is recommended minimum 4 weeks after the first irPD assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B46FAD0-7612-3F97-E053-F662850A260F","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"KUMMEROA","dateModified":"2022-08-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B4757C3-0023-07ED-E053-F662850A267F","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"ONEDATA","dateModified":"2017-10-11","deletedIndicator":"No"},{"value":"irNN","valueDescription":"irNN","ValueMeaning":{"publicId":"6001383","version":"1","preferredName":"irNN","longName":"6001383","preferredDefinition":"No target disease was identified at baseline and at follow-up the patient fails to meet criteria for irCR or irPD.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"irRECIST No Baseline Disease","conceptCode":"C140318","definition":"No target disease was identified at baseline and at follow-up the patient fails to meet criteria for irCR or irPD.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4757C3-002F-07ED-E053-F662850A267F","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B4757C3-0048-07ED-E053-F662850A267F","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"ONEDATA","dateModified":"2017-10-11","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"2568055","version":"1","preferredName":"Not Done","longName":"2568055","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"REEVESD","dateModified":"2014-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E12379-BC2E-07E2-E053-F662850A9029","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"},{"value":"Not evaluated","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"77E12379-BC42-07E2-E053-F662850A9029","beginDate":"2018-10-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-10-10","modifiedBy":"ONEDATA","dateModified":"2018-10-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6001788","version":"1","preferredName":"Immune-related Response Evaluation Criteria In Solid Tumors Non-Target Type","preferredDefinition":"A set of criteria for capturing the unidimensional measurements which are used to assess the effect of immunotherapeutic agents on solid tumors. These criteria are based on elements of the Immune-Related Response Criteria (irRC) and Immune-related RECIST (irRECIST).:Other than the one for which something is done.:Something distinguishable as an identifiable class based on common qualities.","longName":"C140313:C25592:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-related Response Evaluation Criteria In Solid Tumors","conceptCode":"C140313","definition":"A set of criteria for capturing the unidimensional measurements which are used to assess the effect of immunotherapeutic agents on solid tumors based on elements of Immune-related RECIST (irRECIST).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Non-Target","conceptCode":"C25592","definition":"Other than the one for which something is done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B4882A9-38B8-075D-E053-F662850A6271","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"ONEDATA","dateModified":"2017-10-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5B4757C3-0001-07ED-E053-F662850A267F","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"KNABLEJ","dateModified":"2018-10-23","changeDescription":"10/23/18 jk chg reg status to Standard for RECIST defined PV list; do not add PVs without checking latest version of guideline. 10/10/18 tt added 2 PVs per FG recommendation.  10/12/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635324","version":"1","longName":"RECIST","context":"NCI Standards"},{"publicId":"6006642","version":"1","longName":"irRECIST","context":"NCI Standards"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"NCI Standards","type":"USED_BY","context":"NCI Standards"}],"ReferenceDocuments":[{"name":"Non-target lesion response","type":"Preferred Question Text","description":"Non-target lesion response","url":null,"context":"NCI Standards"},{"name":"Pr Marg Text - 1","type":"Alternate Question Text","description":"irRECIST non tumor burden lesion response","url":null,"context":"NCIP"},{"name":"irRECIST","type":"Alternate Question Text","description":"Non-target lesion","url":null,"context":"NCI Standards"}],"origin":"irRECIST: Immune-related Response Evaluation Criteria in Solid Tumours (RECIST)-2013","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5B4766A1-3BBB-0414-E053-F662850ACA58","latestVersionIndicator":"Yes","beginDate":"2017-10-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-10-11","modifiedBy":"KNABLEJ","dateModified":"2018-10-21","changeDescription":"10/7/18 jk Changed registration status to \"Standard\" per Fall 2018 Content Team review.   10/17/17 jk updated short name and pref question text for consistency with RECISTv1.1 Standard CDE.  10/11/17 LS created based on irRECIST guideline.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}